To tackle the human health challenges that face the world today, the FNIH develops collaborations with top experts from government, industry, academia and the not-for-profit sector and provides a neutral environment where we can work productively toward a common goal.
The Dr. Anita Roberts Memorial Fund awards travel scholarships for graduate students and post-doctoral fellows to present their work at a national meeting.
Celebrating the 30th Anniversary of the National Institute of Nursing Research (NINR), the Advancing Science, Improving Lives symposia and scholarly events will bring together scientists, healthcare professionals and members of the public to discuss the advancements in nursing science that build the foundation of clinical nursing practice.
The Dr. John L. Barr Memorial Fund supports the Intramural Research Training Award (IRTA) fellowship program at the Clinical Center's Pain and Palliative Care Service.
The Adam J. Berry Memorial Fund assists early career Australian scientists with travel between Australia and the United States to work at the NIH.
The MRSP is a one-year intensive training program on the NIH campus for up to 50 medical, dental and veterinary students to engage them in research early in their careers.
The Principles of Clinical Pharmacology Course at the NIH Clinical Center trains scholars and researchers in the clinical pharmacologic aspects of contemporary drug development and utilization. Since 1998, more than 10,000 individuals have taken the lecture-based course. The FNIH supported this program from 2009-2015.
The Osteoarthritis Initiative was a public-private collaboration to improve the efficiency of drug development and clinical trials for the treatment of osteoarthritis, which affects more than 30 million adults in the United States.
The Baby Connectome Project (BCP) is a four-year study of children from birth through five years of age, intended to provide a better understanding of how the brain develops from infancy through early childhood and the factors that contribute to healthy brain development.
Development & Production of Endotoxin under GMP for Human Clinical Research is a program enabling NIH to develop and produce a new strain of endotoxin under good manufacturing practices (GMP) conditions.
Lung-MAP is an umbrella protocol which contains a screening component and multiple independently conducted and analyzed treatment sub-studies. The overarching hypothesis is that the umbrella master protocol will establish genomic screening for a large population of previously treated Non-small cell Lung Cancer (NSCLC) patients and evaluate targeted therapies (or combinations) in biomarker-driven sub-studies and immunotherapy combinations in patients previously exposed to standard checkpoint inhibitor therapy and lead to regulatory approval of efficacious regimens.